BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lan RY, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W, Moritoki Y, Ansari AA, Kemper C, Price J. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun. 2009;32:43-51. [PMID: 19101114 DOI: 10.1016/j.jaut.2008.11.001] [Cited by in Crossref: 135] [Cited by in F6Publishing: 131] [Article Influence: 9.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Shi Y, Wang X, Ma H, Liu Q, Gao Y, Niu J. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis. Front Immunol 2022;13:940688. [DOI: 10.3389/fimmu.2022.940688] [Reference Citation Analysis]
2 Jia H, Chen J, Zhang X, Bi K, Zhou H, Liu T, Xu J, Diao H. IL-17A produced by invariant natural killer T cells and CD3+ CD56+ αGalcer-CD1d tetramer- T cells promote liver fibrosis in patients with primary biliary cholangitis. J Leukoc Biol 2022. [PMID: 35730799 DOI: 10.1002/JLB.2A0622-586RRRR] [Reference Citation Analysis]
3 Yang Y, Dong G, Bi Y, Zhang X, Yao X, Jin G, Zhang K, Shu Z, Hong F. Human liver stem cells alleviate Con-A induced liver injury by regulating the balance of Treg/Th17 cells. Transpl Immunol 2022;:101632. [PMID: 35623594 DOI: 10.1016/j.trim.2022.101632] [Reference Citation Analysis]
4 Chen J, Li X, Zeng P, Zhang X, Bi K, Lin C, Jiang J, Diao H. Lamina propria interleukin 17 A aggravates natural killer T-cell activation in autoimmune hepatitis. FASEB J 2022;36:e22346. [PMID: 35583908 DOI: 10.1096/fj.202101734RRR] [Reference Citation Analysis]
5 Zhao Y, Yin Z, Du H, Huang K, Zhang F, Chen H. The latest research trends in primary biliary cholangitis: a bibliometric analysis. Clin Exp Med 2022. [PMID: 35389157 DOI: 10.1007/s10238-022-00825-0] [Reference Citation Analysis]
6 Akberova D, Kiyasov IA, Abdulganieva D, Odintsova A. Changes of Serum Cytokine Levels and Relation to Clinical Specificity in Patients with Primary Biliary Cholangitis. BioNanoSci . [DOI: 10.1007/s12668-022-00937-7] [Reference Citation Analysis]
7 Lee TL, Tsai TF. Non-immune functions of inflammatory cytokines targeted by anti-psoriatic biologics: a review. Inflamm Res 2022. [PMID: 34981130 DOI: 10.1007/s00011-021-01528-0] [Reference Citation Analysis]
8 Sirbe C, Simu G, Szabo I, Grama A, Pop TL. Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms. Int J Mol Sci 2021;22:13578. [PMID: 34948375 DOI: 10.3390/ijms222413578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
9 Kartasheva-Ebertz DM, Pol S, Lagaye S. Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis. Front Immunol 2021;12:691073. [PMID: 34211477 DOI: 10.3389/fimmu.2021.691073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Kumar N, Surani S, Udeani G, Mathew S, John S, Sajan S, Mishra J. Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies. Life Sci 2021;278:119544. [PMID: 33945827 DOI: 10.1016/j.lfs.2021.119544] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
11 Yan N, Yan T, Xia Y, Hao H, Wang G, Gonzalez FJ. The pathophysiological function of non-gastrointestinal farnesoid X receptor. Pharmacol Ther 2021;226:107867. [PMID: 33895191 DOI: 10.1016/j.pharmthera.2021.107867] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Stein S, Henze L, Poch T, Carambia A, Krech T, Preti M, Schuran FA, Reich M, Keitel V, Fiorotto R, Strazzabosco M, Fischer L, Li J, Müller LM, Wagner J, Gagliani N, Herkel J, Schwinge D, Schramm C. IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression. J Hepatol 2021;74:919-30. [PMID: 33197512 DOI: 10.1016/j.jhep.2020.10.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Liu SP, Bian ZH, Zhao ZB, Wang J, Zhang W, Leung PSC, Li L, Lian ZX. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review. Clin Rev Allergy Immunol 2020;58:252-71. [PMID: 32076943 DOI: 10.1007/s12016-020-08778-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Fiers WD, Leonardi I, Iliev ID. From Birth and Throughout Life: Fungal Microbiota in Nutrition and Metabolic Health. Annu Rev Nutr 2020;40:323-43. [PMID: 32680437 DOI: 10.1146/annurev-nutr-013120-043659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Ronca V, Mancuso C, Milani C, Carbone M, Oo YH, Invernizzi P. Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis. J Leukoc Biol 2020;108:659-71. [PMID: 32349179 DOI: 10.1002/JLB.5MR0320-200R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 An J. Expression and Significance of Th17 Cells and Related Factors in Patients with Autoimmune Hepatitis. Comb Chem High Throughput Screen 2019;22:232-7. [PMID: 30947662 DOI: 10.2174/1386207322666190402160455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
17 Cai S, Li M, Boyer JL. The Role of Bile Acid‐Mediated Inflammation in Cholestatic Liver Injury. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 728-36. [DOI: 10.1002/9781119436812.ch56] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 Chen Q, Lai L, Chi X, Lu X, Wu H, Sun J, Wu W, Cai L, Zeng X, Wang C, Chen W, Peng A. CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis. Mediators Inflamm 2020;2020:3019378. [PMID: 32104147 DOI: 10.1155/2020/3019378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME. The challenges of primary biliary cholangitis: What is new and what needs to be done. J Autoimmun 2019;105:102328. [PMID: 31548157 DOI: 10.1016/j.jaut.2019.102328] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
20 Soroka CJ, Assis DN, Alrabadi LS, Roberts S, Cusack L, Jaffe AB, Boyer JL. Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile. Hepatology 2019;70:871-82. [PMID: 30561836 DOI: 10.1002/hep.30470] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
21 Jeffery HC, Hunter S, Humphreys EH, Bhogal R, Wawman RE, Birtwistle J, Atif M, Bagnal CJ, Rodriguez Blanco G, Richardson N, Warner S, Dunn WB, Afford SC, Adams DH, Oo YH. Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases. J Immunol 2019;203:1151-9. [PMID: 31391236 DOI: 10.4049/jimmunol.1800455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Sun Q, Wang Q, Feng N, Meng Y, Li B, Luo D, Shang X, Lv J, Monsaf AM, Wang C, Ma X. The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis. Ann Transl Med 2019;7:389. [PMID: 31555703 DOI: 10.21037/atm.2019.07.100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Arsenijevic A, Milovanovic J, Stojanovic B, Djordjevic D, Stanojevic I, Jankovic N, Vojvodic D, Arsenijevic N, Lukic ML, Milovanovic M. Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice. Front Immunol 2019;10:1309. [PMID: 31231399 DOI: 10.3389/fimmu.2019.01309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
24 Ma W, Chen D. Immunological abnormalities in patients with primary biliary cholangitis. Clinical Science 2019;133:741-60. [DOI: 10.1042/cs20181123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
25 Zhang H, Jiang Z, Zhang L. Dual effect of T helper cell 17 (Th17) and regulatory T cell (Treg) in liver pathological process: From occurrence to end stage of disease.Int Immunopharmacol. 2019;69:50-59. [PMID: 30669025 DOI: 10.1016/j.intimp.2019.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
26 Beringer A, Miossec P. IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases. Autoimmun Rev. 2018;17:1176-1185. [PMID: 30321671 DOI: 10.1016/j.autrev.2018.06.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
27 Cichoż-Lach H, Grywalska E, Michalak A, Kowalik A, Mielnik M, Roliński J. Deviations in Peripheral Blood Cell Populations are Associated with the Stage of Primary Biliary Cholangitis and Presence of Itching. Arch Immunol Ther Exp (Warsz) 2018;66:443-52. [PMID: 29951695 DOI: 10.1007/s00005-018-0515-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
28 Jiang X, Lian M, Li Y, Zhang W, Wang Q, Wei Y, Zhang J, Chen W, Xiao X, Miao Q, Bian Z, Qiu D, Fang J, Ansari AA, Leung PSC, Coppel RL, Tang R, Gershwin ME, Ma X. The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: Regulation by cholic acid-induced Interleukin-7. J Autoimmun. 2018;90:64-75. [PMID: 29429758 DOI: 10.1016/j.jaut.2018.01.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
29 Milosavljevic N, Gazdic M, Simovic Markovic B, Arsenijevic A, Nurkovic J, Dolicanin Z, Jovicic N, Jeftic I, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells - an experimental study. Transpl Int. 2018;31:102-115. [PMID: 28805262 DOI: 10.1111/tri.13023] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
30 Wu MS, Wang CH, Tseng FC, Yang HJ, Lo YC, Kuo YP, Tsai DJ, Tsai WT, Yu GY. Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma. Infect Agent Cancer 2017;12:42. [PMID: 28770001 DOI: 10.1186/s13027-017-0152-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yang X, Li J, Liu J, Gao M, Zhou L, Lu W. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study. Medicine (Baltimore) 2017;96:e7064. [PMID: 28591041 DOI: 10.1097/MD.0000000000007064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
32 Mailer RKW, Gisterå A, Polyzos KA, Ketelhuth DFJ, Hansson GK. Hypercholesterolemia Induces Differentiation of Regulatory T Cells in the Liver. Circ Res 2017;120:1740-53. [PMID: 28420668 DOI: 10.1161/CIRCRESAHA.116.310054] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 6.4] [Reference Citation Analysis]
33 Li X, Su Y, Hua X, Xie C, Liu J, Huang Y, Zhou L, Zhang M, Li X, Gao Z. Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis. J Transl Med. 2017;15:75. [PMID: 28399886 DOI: 10.1186/s12967-017-1167-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
34 Kempinska-Podhorodecka A, Milkiewicz M, Wasik U, Ligocka J, Zawadzki M, Krawczyk M, Milkiewicz P. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway. Int J Mol Sci 2017;18:E289. [PMID: 28146070 DOI: 10.3390/ijms18020289] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
35 Ali AH, Tabibian JH, Carey EJ, Lindor KD. Emerging drugs for the treatment of Primary Biliary Cholangitis. Expert Opin Emerg Drugs 2016;21:39-56. [PMID: 26901615 DOI: 10.1517/14728214.2016.1150999] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
36 Syu BJ, Loh CE, Hsueh YH, Gershwin ME, Chuang YH. Dual Roles of IFN-γ and IL-4 in the Natural History of Murine Autoimmune Cholangitis: IL-30 and Implications for Precision Medicine. Sci Rep 2016;6:34884. [PMID: 27721424 DOI: 10.1038/srep34884] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
37 Tian J, Yang G, Chen HY, Hsu DK, Tomilov A, Olson KA, Dehnad A, Fish SR, Cortopassi G, Zhao B, Liu FT, Gershwin ME, Török NJ, Jiang JX. Galectin-3 regulates inflammasome activation in cholestatic liver injury. FASEB J 2016;30:4202-13. [PMID: 27630169 DOI: 10.1096/fj.201600392RR] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
38 Giles DA, Moreno-Fernandez ME, Divanovic S. IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression. Curr Drug Targets 2015;16:1315-23. [PMID: 26028039 DOI: 10.2174/1389450116666150531153627] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
39 Gu L, Deng WS, Sun XF, Zhou H, Xu Q. Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance. Mol Med Rep 2016;14:1153-61. [PMID: 27315465 DOI: 10.3892/mmr.2016.5392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
40 Shuai Z, Leung MW, He X, Zhang W, Yang G, Leung PS, Eric Gershwin M. Adaptive immunity in the liver. Cell Mol Immunol 2016;13:354-68. [PMID: 26996069 DOI: 10.1038/cmi.2016.4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
41 Bandyopadhyay K, Marrero I, Kumar V. NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol 2016;13:337-46. [PMID: 26972772 DOI: 10.1038/cmi.2015.115] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 12.3] [Reference Citation Analysis]
42 Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Cappelletti M, Huppert SS, Iwakura Y, Dong C, Shanmukhappa SK, Divanovic S. Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis. PLoS One. 2016;11:e0149783. [PMID: 26895034 DOI: 10.1371/journal.pone.0149783] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
43 Shi T, Zhang T, Zhang L, Yang Y, Zhang H, Zhang F. The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis. Medicine (Baltimore). 2015;94:e1888. [PMID: 26554784 DOI: 10.1097/md.0000000000001888] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
44 Klemann C, Schröder A, Dreier A, Möhn N, Dippel S, Winterberg T, Wilde A, Yu Y, Thorenz A, Gueler F, Jörns A, Tolosa E, Leonhardt J, Haas JD, Prinz I, Vieten G, Petersen C, Kuebler JF. Interleukin 17, Produced by γδ T Cells, Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and Is Increased in Livers of Patients. Gastroenterology 2016;150:229-241.e5. [DOI: 10.1053/j.gastro.2015.09.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
45 Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin ME. The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol 2015;48:301-15. [PMID: 25682089 DOI: 10.1007/s12016-015-8471-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
46 Rau M, Schilling AK, Meertens J, Hering I, Weiss J, Jurowich C, Kudlich T, Hermanns HM, Bantel H, Beyersdorf N. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver. J Immunol. 2016;196:97-105. [PMID: 26621860 DOI: 10.4049/jimmunol.1501175] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 13.9] [Reference Citation Analysis]
47 Mak A, Uetrecht J. The Combination of Anti-CTLA-4 and PD1-/- Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury. Chem Res Toxicol 2015;28:2287-91. [PMID: 26529122 DOI: 10.1021/acs.chemrestox.5b00305] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
48 Kirbas A, Biberoglu E, Ersoy AO, Dikmen AU, Koca C, Erdinc S, Uygur D, Caglar T, Biberoglu K. The role of interleukin-17 in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med 2016;29:977-81. [PMID: 25845273 DOI: 10.3109/14767058.2015.1028354] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
49 Gao Y, Zhang M, Li J, Yang M, Liu Y, Guo X, Li H, Liu Z, Zhao J. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS One 2015;10:e0137881. [PMID: 26367459 DOI: 10.1371/journal.pone.0137881] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
50 Kouroumalis E, Notas G. Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther 2015; 6(3): 32-58 [PMID: 26261733 DOI: 10.4292/wjgpt.v6.i3.32] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
51 Zhang H, Bernuzzi F, Lleo A, Ma X, Invernizzi P. Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases. Mediators Inflamm 2015;2015:436450. [PMID: 26146463 DOI: 10.1155/2015/436450] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
52 Chang CH, Chen YC, Zhang W, Leung PS, Gershwin ME, Chuang YH. Innate immunity drives the initiation of a murine model of primary biliary cirrhosis. PLoS One. 2015;10:e0121320. [PMID: 25807531 DOI: 10.1371/journal.pone.0121320] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
53 Bian F, Barbosa FL, Corrales RM, Pelegrino FS, Volpe EA, Pflugfelder SC, de Paiva CS. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome. Arthritis Res Ther 2015;17:53. [PMID: 25889094 DOI: 10.1186/s13075-015-0582-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
54 Hill R, Quaglia A, Hussain M, Hadzic N, Mieli-Vergani G, Vergani D, Davenport M. Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome. J Pediatr Surg 2015;50:1297-303. [PMID: 25783388 DOI: 10.1016/j.jpedsurg.2015.02.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
55 Schwinge D, Carambia A, Quaas A, Krech T, Wegscheid C, Tiegs G, Prinz I, Lohse AW, Herkel J, Schramm C. Testosterone Suppresses Hepatic Inflammation by the Downregulation of IL-17, CXCL-9, and CXCL-10 in a Mouse Model of Experimental Acute Cholangitis. J I 2015;194:2522-30. [DOI: 10.4049/jimmunol.1400076] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
56 Mousa HS, Lleo A, Invernizzi P, Bowlus CL, Gershwin ME. Advances in pharmacotherapy for primary biliary cirrhosis. Expert Opin Pharmacother. 2015;16:633-643. [PMID: 25543678 DOI: 10.1517/14656566.2015.998650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
57 Ma HD, Wang YH, Chang C, Gershwin ME, Lian ZX. The intestinal microbiota and microenvironment in liver. Autoimmun Rev. 2015;14:183-191. [PMID: 25315744 DOI: 10.1016/j.autrev.2014.10.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
58 Chang CH, Chen YC, Yu YH, Tao MH, Leung PS, Ansari AA, Gershwin ME, Chuang YH. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis. Clin Exp Immunol. 2014;177:373-380. [PMID: 24547942 DOI: 10.1111/cei.12298] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
59 Hammerich L, Tacke F. Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clin Exp Gastroenterol. 2014;7:297-306. [PMID: 25214799 DOI: 10.2147/ceg.s43737] [Cited by in Crossref: 32] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
60 Yang W, Yao Y, Yang YQ, Lu FT, Li L, Wang YH, Nakajima T, Tsuneyama K, Ridgway WM, Gershwin ME, Lian ZX. Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice. PLoS One 2014;9:e105351. [PMID: 25133396 DOI: 10.1371/journal.pone.0105351] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
61 Lleo A, Maroni L, Glaser S, Alpini G, Marzioni M. Role of cholangiocytes in primary biliary cirrhosis. Semin Liver Dis 2014;34:273-84. [PMID: 25057951 DOI: 10.1055/s-0034-1383727] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
62 Wu L, Ong S, Talor MV, Barin JG, Baldeviano GC, Kass DA, Bedja D, Zhang H, Sheikh A, Margolick JB, Iwakura Y, Rose NR, Ciháková D. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J Exp Med 2014;211:1449-64. [PMID: 24935258 DOI: 10.1084/jem.20132126] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 11.0] [Reference Citation Analysis]
63 Berrih-Aknin S. Myasthenia Gravis: paradox versus paradigm in autoimmunity. J Autoimmun. 2014;52:1-28. [PMID: 24934596 DOI: 10.1016/j.jaut.2014.05.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
64 Czaja AJ. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets. Aliment Pharmacol Ther 2014;40:261-79. [DOI: 10.1111/apt.12825] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
65 Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP, Bowlus CL, Yang GX, Leung PS, Ansari AA, Wu L, Coppel RL, Gershwin ME. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 2014;59:1944-53. [PMID: 24375552 DOI: 10.1002/hep.26979] [Cited by in Crossref: 130] [Cited by in F6Publishing: 122] [Article Influence: 16.3] [Reference Citation Analysis]
66 Yao Y, Yang W, Yang YQ, Ma HD, Lu FT, Li L, Tao YY, Tsuneyama K, Zhang W, Friedman S. Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα(-/-) mice. J Autoimmun. 2014;51:99-108. [PMID: 24651036 DOI: 10.1016/j.jaut.2014.02.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 6.5] [Reference Citation Analysis]
67 Chentoufi AA, Serov YA, Alazmi M, Baba K. Immune Components of Liver Damage Associated with Connective Tissue Diseases. J Clin Transl Hepatol 2014;2:37-44. [PMID: 26357616 DOI: 10.14218/JCTH.2014.00001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
68 Shi TY, Zhang FC. Role of autoimmunity in primary biliary cirrhosis. World J Gastroenterol. 2012;18:7141-7148. [PMID: 23326118 DOI: 10.3748/wjgv.18.i48.7141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Zheng L, Chu J, Shi Y, Zhou X, Tan L, Li Q, Cui L, Han Z, Han Y, Fan D. Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17. Cell Biosci. 2013;3:46. [PMID: 24314294 DOI: 10.1186/2045-3701-3-46] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
70 Abe M, Hiasa Y, Onji M. T helper 17 cells in autoimmune liver diseases. Clin Dev Immunol. 2013;2013:607073. [PMID: 24223606 DOI: 10.1155/2013/607073] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
71 Kawata K, Tsuda M, Yang GX, Zhang W, Tanaka H, Tsuneyama K, Leung P, He XS, Knechtle S, Ansari AA. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis. PLoS One. 2013;8:e74225. [PMID: 24040208 DOI: 10.1371/journal.pone.0074225] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
72 O'Brien KM, Allen KM, Rockwell CE, Towery K, Luyendyk JP, Copple BL. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis. Am J Pathol 2013;183:1498-507. [PMID: 24012680 DOI: 10.1016/j.ajpath.2013.07.019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
73 Xu R, Tao A, Zhang S, Zhang M. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice. Acta Biochim Biophys Sin (Shanghai) 2013;45:726-33. [PMID: 23786840 DOI: 10.1093/abbs/gmt065] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
74 Licata LA, Nguyen CT, Burga RA, Falanga V, Espat NJ, Ayala A, Thorn M, Junghans RP, Katz SC. Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol 2013;94:813-23. [PMID: 23883516 DOI: 10.1189/jlb.0313137] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
75 Liberal R, Grant CR, Sakkas L, Bizzaro N, Bogdanos DP. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol. 2013;37:572-585. [PMID: 23876351 DOI: 10.1016/j.clinre.2013.04.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
76 Xue ZM, Yao DM. Th17 cells and liver diseases. Shijie Huaren Xiaohua Zazhi 2013; 21(13): 1185-1190 [DOI: 10.11569/wcjd.v21.i13.1185] [Reference Citation Analysis]
77 Danzer C, Mattner J. Impact of microbes on autoimmune diseases. Arch Immunol Ther Exp (Warsz) 2013;61:175-86. [PMID: 23417246 DOI: 10.1007/s00005-013-0216-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
78 Tsuda M, Zhang W, Yang GX, Tsuneyama K, Ando Y, Kawata K, Park O, Leung PS, Coppel RL, Ansari AA, Ridgway WM, Gao B, Lian ZX, Flavell R, He XS, Gershwin ME. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice. Hepatology 2013;57:806-16. [PMID: 22576253 DOI: 10.1002/hep.25829] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 7.9] [Reference Citation Analysis]
79 Shi TY, Zhang FC. Role of autoimmunity in primary biliary cirrhosis. World J Gastroenterol 2012; 18(48): 7141-7148 [PMID: 23326118 DOI: 10.3748/wjg.v18.i48.7141] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
80 Zhang Y, Wang X, Zhong M, Zhang M, Suo Q, Lv K. MicroRNA let-7a ameliorates con A-induced hepatitis by inhibiting IL-6-dependent Th17 cell differentiation. J Clin Immunol 2013;33:630-9. [PMID: 23184091 DOI: 10.1007/s10875-012-9840-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
81 Carambia A, Herkel J. Th17 cells bound for the liver: Group tourists or private travellers? Journal of Hepatology 2012;57:943-5. [DOI: 10.1016/j.jhep.2012.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
82 Ngalamika O, Zhang Y, Yin H, Zhao M, Gershwin ME, Lu Q. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. J Autoimmun. 2012;39:451-465. [PMID: 23084980 DOI: 10.1016/j.jaut.2012.09.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
83 Ando Y, Yang GX, Tsuda M, Kawata K, Zhang W, Nakajima T, Tsuneyama K, Leung P, Lian ZX, Okazaki K, Ridgway WM, Norman GL, Ansari AA, He XS, Coppel RL, Gershwin ME. The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice. Hepatology 2012;56:1418-26. [PMID: 22532156 DOI: 10.1002/hep.25803] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
84 Hurt RT, Matheson PJ, Smith JW, Zakaria el R, Shaheen SP, McClain CJ, Garrison RN. Preservation of hepatic blood flow by direct peritoneal resuscitation improves survival and prevents hepatic inflammation following hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 2012;303:G1144-52. [PMID: 22997198 DOI: 10.1152/ajpgi.00278.2011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
85 Folci M, Meda F, Gershwin ME, Selmi C. Cutting-edge issues in primary biliary cirrhosis. Clin Rev Allergy Immunol 2012;42:342-54. [PMID: 21243445 DOI: 10.1007/s12016-011-8253-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
86 Zhang SC, Zheng YH, Yu PP, Min TH, Yu FX, Ye C, Xie YK, Zhang QY. Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6. World J Gastroenterol 2012; 18(28): 3696-3704 [PMID: 22851861 DOI: 10.3748/wjg.v18.i28.3696] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
87 Invernizzi P, Alessio MG, Smyk DS, Lleo A, Sonzogni A, Fabris L, Candusso M, Bogdanos DP, Iorio R, Torre G. Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterol 2012;12:92. [PMID: 22816667 DOI: 10.1186/1471-230X-12-92] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
88 Oo YH, Banz V, Kavanagh D, Liaskou E, Withers DR, Humphreys E, Reynolds GM, Lee-Turner L, Kalia N, Hubscher SG, Klenerman P, Eksteen B, Adams DH. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J Hepatol 2012;57:1044-51. [PMID: 22796894 DOI: 10.1016/j.jhep.2012.07.008] [Cited by in Crossref: 117] [Cited by in F6Publishing: 113] [Article Influence: 11.7] [Reference Citation Analysis]
89 Sousa GM, Oliveira IS, Andrade LJ, Sousa-Atta ML, Paraná R, Atta AM. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection. Cytokine. 2012;60:138-142. [PMID: 22748467 DOI: 10.1016/j.cyto.2012.06.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
90 Tanaka H, Leung PSC, Kenny TP, Gershwin ME, Bowlus CL. Immunological Orchestration of Liver Fibrosis. Clinic Rev Allerg Immunol 2012;43:220-9. [DOI: 10.1007/s12016-012-8323-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
91 Lee YS, Jeong WI. Retinoic acids and hepatic stellate cells in liver disease. J Gastroenterol Hepatol. 2012;27 Suppl 2:75-79. [PMID: 22320921 DOI: 10.1111/j.1440-1746.2011.07007.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
92 Fenoglio D, Bernuzzi F, Battaglia F, Parodi A, Kalli F, Negrini S, De Palma R, Invernizzi P, Filaci G. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev. 2012;12:300-304. [PMID: 22634708 DOI: 10.1016/j.autrev.2012.05.004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
93 Chang Q, Wang YK, Zhao Q, Wang CZ, Hu YZ, Wu BY. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2012;27:273-278. [PMID: 21592230 DOI: 10.1111/j.1440-1746.2011.06782.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
94 Trivedi PJ, Cullen S. Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments. Hepatol Int 2013;7:28-47. [PMID: 26201620 DOI: 10.1007/s12072-012-9362-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
95 Bowen DG. Finding a role for Th17 cells in hepatitis C pathogenesis: Editorials. Journal of Gastroenterology and Hepatology 2012;27:188-91. [DOI: 10.1111/j.1440-1746.2011.07033.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
96 Tang Y, Bian Z, Zhao L, Liu Y, Liang S, Wang Q, Han X, Peng Y, Chen X, Shen L, Qiu D, Li Z, Ma X. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin Exp Immunol. 2011;166:281-290. [PMID: 21985374 DOI: 10.1111/j.1365-2249.2011.04471.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 150] [Article Influence: 13.2] [Reference Citation Analysis]
97 Maddur MS, Kaveri SV, Bayry J. Comparison of different IVIg preparations on IL-17 production by human Th17 cells. Autoimmunity Reviews 2011;10:809-10. [DOI: 10.1016/j.autrev.2011.02.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
98 Tsuda M, Ambrosini YM, Zhang W, Yang GX, Ando Y, Rong G, Tsuneyama K, Sumida K, Shimoda S, Bowlus CL, Leung PS, He XS, Coppel RL, Ansari AA, Lian ZX, Gershwin ME. Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis. Hepatology 2011;54:1293-302. [PMID: 21735469 DOI: 10.1002/hep.24526] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
99 Raychaudhuri SP, Raychaudhuri SK, Genovese MC. IL-17 receptor and its functional significance in psoriatic arthritis. Mol Cell Biochem 2012;359:419-29. [PMID: 21894442 DOI: 10.1007/s11010-011-1036-6] [Cited by in Crossref: 127] [Cited by in F6Publishing: 124] [Article Influence: 11.5] [Reference Citation Analysis]
100 Harada K, Nakanuma Y. Cholangiopathy with respect to biliary innate immunity. Int J Hepatol. 2012;2012:793569. [PMID: 21994888 DOI: 10.1155/2012/793569] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
101 Raychaudhuri SK, Raychaudhuri SP. Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases. Indian J Dermatol 2010;55:157-60. [PMID: 20606886 DOI: 10.4103/0019-5154.62752] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
102 Zhai S, Zhang L, Dang S, Yu Y, Zhao Z, Zhao W, Liu L. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol. 2011;24:303-310. [PMID: 21721931 DOI: 10.1089/vim.2010.0135] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
103 Santodomingo-Garzon T, Swain MG. Role of NKT cells in autoimmune liver disease. Autoimmun Rev. 2011;10:793-800. [PMID: 21740985 DOI: 10.1016/j.autrev.2011.06.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
104 Yan S, Wang L, Liu N, Wang Y, Chu Y. Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol Cell Biol. 2012;90:421-428. [PMID: 21691280 DOI: 10.1038/icb.2011.59] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
105 Mohammed JP, Fusakio ME, Rainbow DB, Moule C, Fraser HI, Clark J, Todd JA, Peterson LB, Savage PB, Wills-Karp M. Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol. 2011;187:337-349. [PMID: 21613619 DOI: 10.4049/jimmunol.1003525] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
106 Zhao L, Tang Y, You Z, Wang Q, Liang S, Han X, Qiu D, Wei J, Liu Y, Shen L, Chen X, Peng Y, Li Z, Ma X. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One. 2011;6:e18909. [PMID: 21526159 DOI: 10.1371/journal.pone.0018909] [Cited by in Crossref: 125] [Cited by in F6Publishing: 124] [Article Influence: 11.4] [Reference Citation Analysis]
107 de Carvalho JF, Pereira RM, Shoenfeld Y. Pearls in autoimmunity. Auto Immun Highlights 2011;2:1-4. [PMID: 26000114 DOI: 10.1007/s13317-011-0016-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
108 Lied GA, Berstad A. Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Scand J Immunol. 2011;73:1-7. [PMID: 21128997 DOI: 10.1111/j.1365-3083.2010.02470.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
109 Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol. 2011;2011:345803. [PMID: 21197451 DOI: 10.1155/2011/3458033010664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011;2011:345803. [PMID: 21197451 DOI: 10.1155/2011/345803] [Cited by in Crossref: 151] [Cited by in F6Publishing: 165] [Article Influence: 12.6] [Reference Citation Analysis]
111 Ye C, Li WY, Zheng MH, Chen YP. T-helper 17 cell: A distinctive cell in liver diseases. Hepatol Res. 2011;41:22-29. [PMID: 21108703 DOI: 10.1111/j.1872-034x.2010.00744.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
112 Voumvouraki A, Koulentaki M, Tzardi M, Sfakianaki O, Manousou P, Notas G, Kouroumalis E. Increased ΤGF-β3 in primary biliary cirrhosis: An abnormality related to pathogenesis? World J Gastroenterol 2010; 16(40): 5057-5064 [PMID: 20976842 DOI: 10.3748/wjg.v16.i40.5057] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
113 Ye Y, Xie X, Yu J, Zhou L, Xie H, Jiang G, Yu X, Zhang W, Wu J, Zheng S. Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol. 2010;30:546-555. [PMID: 20393789 DOI: 10.1007/s10875-010-9416-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 5.2] [Reference Citation Analysis]
114 Selmi C, Mackay IR, Gershwin ME. The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol 2011;89:70-80. [PMID: 20975735 DOI: 10.1038/icb.2010.126] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
115 Selmi C, Affronti A, Ferrari L, Invernizzi P. Immune-mediated bile duct injury: The case of primary biliary cirrhosis. World J Gastrointest Pathophysiol 2010; 1(4): 118-128 [PMID: 21607152 DOI: 10.4291/wjgp.v1.i4.118] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
116 Selmi C. Autoimmunity in 2009. Autoimmunity Reviews 2010;9:795-800. [DOI: 10.1016/j.autrev.2010.08.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
117 Zhao L, Qiu de K, Ma X. Th17 cells: the emerging reciprocal partner of regulatory T cells in the liver. J Dig Dis. 2010;11:126-133. [PMID: 20579216 DOI: 10.1111/j.1751-2980.2010.00428.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
118 Hirschfield GM, Heathcote EJ, Gershwin ME. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology. 2010;139:1481-1496. [PMID: 20849855 DOI: 10.1053/j.gastro.2010.09.004] [Cited by in Crossref: 167] [Cited by in F6Publishing: 152] [Article Influence: 13.9] [Reference Citation Analysis]
119 Yu H, Huang J, Liu Y, Ai G, Yan W, Wang X, Ning Q. IL-17 contributes to autoimmune hepatitis. J Huazhong Univ Sci Technolog Med Sci. 2010;30:443-446. [PMID: 20714867 DOI: 10.1007/s11596-010-0446-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
120 Tsuda M, Torgerson TR, Selmi C, Gambineri E, Carneiro-Sampaio M, Mannurita SC, Leung PS, Norman GL, Gershwin ME. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun. 2010;35:265-268. [PMID: 20650610 DOI: 10.1016/j.jaut.2010.06.017] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
121 Juran BD, Lazaridis KN. Update on the genetics and genomics of PBC. J Autoimmun. 2010;35:181-187. [PMID: 20638243 DOI: 10.1016/j.jaut.2010.06.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
122 Bernuzzi F, Fenoglio D, Battaglia F, Fravega M, Gershwin ME, Indiveri F, Ansari AA, Podda M, Invernizzi P, Filaci G. Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun. 2010;35:176-180. [PMID: 20638239 DOI: 10.1016/j.jaut.2010.06.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
123 Brandon JA, Perez J, Jennings CD, Cohen DA, Sindhava VJ, Bondada S, Kaplan AM, Bryson JS. Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease. Am J Physiol Gastrointest Liver Physiol 2010;299:G602-13. [PMID: 20634434 DOI: 10.1152/ajpgi.00511.2009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
124 Zhang W, Tsuda M, Yang GX, Tsuneyama K, Rong G, Ridgway WM, Ansari AA, Flavell RA, Coppel RL, Lian ZX, Gershwin ME. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis. Hepatology 2010;52:215-22. [PMID: 20578264 DOI: 10.1002/hep.23664] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
125 Oo YH, Shetty S, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. Dig Dis. 2010;28:31-44. [PMID: 20460888 DOI: 10.1159/000282062] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 6.8] [Reference Citation Analysis]
126 Poupon R. Primary biliary cirrhosis: A 2010 update. Journal of Hepatology 2010;52:745-58. [DOI: 10.1016/j.jhep.2009.11.027] [Cited by in Crossref: 195] [Cited by in F6Publishing: 162] [Article Influence: 16.3] [Reference Citation Analysis]
127 Ueno Y, Ambrosini YM, Moritoki Y, Ridgway WM, Gershwin ME. Murine models of autoimmune cholangitis: . Current Opinion in Gastroenterology 2010;26:274-9. [DOI: 10.1097/mog.0b013e32833755aa] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
128 Invernizzi P, Selmi C, Gershwin ME. Update on primary biliary cirrhosis. Dig Liver Dis. 2010;42:401-408. [PMID: 20359968 DOI: 10.1016/j.dld.2010.02.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
129 Lafdil F, Miller AM, Ki SH, Gao B. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol. 2010;7:250-254. [PMID: 20305686 DOI: 10.1038/cmi.2010.5] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
130 Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun. 2010;34:J300-J306. [PMID: 20036105 DOI: 10.1016/j.jaut.2009.12.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 5.1] [Reference Citation Analysis]
131 Selmi C, Meda F, Kasangian A, Invernizzi P, Tian Z, Lian Z, Podda M, Gershwin ME. Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol 2010;7:1-10. [PMID: 20029462 DOI: 10.1038/cmi.2009.104] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
132 Hirschfield GM, Siminovitch KA. Toward the molecular dissection of primary biliary cirrhosis. Hepatology 2009;50:1347-50. [PMID: 19876938 DOI: 10.1002/hep.23252] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
133 Migita K, Ilyassova B, Kovzel EF, Nersesov A, Abiru S, Maeda Y, Komori A, Ito M, Yano K, Yatsuhashi H. Serum BAFF and APRIL levels in patients with PBC. Clin Immunol. 2010;134:217-225. [PMID: 19840904 DOI: 10.1016/j.clim.2009.09.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
134 Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 2009;157:261-70. [PMID: 19604266 DOI: 10.1111/j.1365-2249.2009.03947.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 8.9] [Reference Citation Analysis]
135 Selmi C. A New Year in Autoimmunity. Annals of the New York Academy of Sciences 2009;1173:239-42. [DOI: 10.1111/j.1749-6632.2009.04878.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
136 Carambia A, Herkel J. CD4 T cells in hepatic immune tolerance. J Autoimmun. 2010;34:23-28. [PMID: 19720498 DOI: 10.1016/j.jaut.2009.08.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
137 Nemeth E, Baird AW, O'Farrelly C. Microanatomy of the liver immune system. Semin Immunopathol. 2009;31:333-343. [PMID: 19639317 DOI: 10.1007/s00281-009-0173-4] [Cited by in Crossref: 135] [Cited by in F6Publishing: 123] [Article Influence: 10.4] [Reference Citation Analysis]
138 Hohenester S, Oude-Elferink RP, Beuers U. Primary biliary cirrhosis. Semin Immunopathol. 2009;31:283-307. [PMID: 19603170 DOI: 10.1007/s00281-009-0164-5] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 8.8] [Reference Citation Analysis]
139 Selmi C, Podda M, Gershwin ME. Old and rising stars in the lymphoid liver. Semin Immunopathol 2009;31:279-82. [PMID: 19603169 DOI: 10.1007/s00281-009-0175-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
140 Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol. 2009;31:309-322. [PMID: 19533132 DOI: 10.1007/s00281-009-0167-2] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]